Underrecognized association of porto-sinusoidal vascular disorder and telomere biology disorders.
作者信息
Rattan Puru, Nguyen Kianna, Penrice Daniel D, Povero Davide, Simonetto Douglas A
机构信息
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Medical Scientist Training Program, Mayo Clinic Alix School of Medicine, Rochester, MN, USA.
出版信息
J Hepatol. 2025 Apr;82(4):e199-e200. doi: 10.1016/j.jhep.2024.10.029. Epub 2024 Oct 24.
Abstract
摘要
相似文献
1
Underrecognized association of porto-sinusoidal vascular disorder and telomere biology disorders.门静脉窦状血管疾病与端粒生物学疾病之间未被充分认识的关联。
J Hepatol. 2025 Apr;82(4):e199-e200. doi: 10.1016/j.jhep.2024.10.029. Epub 2024 Oct 24.
2
TERT de novo mutation-associated dyskeratosis congenita and porto-sinusoidal vascular disease: a case report.端粒酶逆转录酶（TERT）新发突变相关的先天性角化不良和肝内门静脉-肝静脉分流性血管病：1例报告
J Med Case Rep. 2025 Jan 23;19(1):32. doi: 10.1186/s13256-025-05031-6.
3
Porto-sinusoidal vascular disorder, report of a novel association with POEMS syndrome. Future challenge for the hepatologist.门静脉窦状隙血管疾病，一种与POEMS综合征新关联的报告。肝脏病学家面临的未来挑战。
Clin Res Hepatol Gastroenterol. 2023 May;47(5):102126. doi: 10.1016/j.clinre.2023.102126. Epub 2023 Apr 15.
4
Hepatopulmonary syndrome in patients with porto-sinusoidal vascular disorder: Characteristics and outcome.肝窦状血管疾病患者的肝肺综合征：特征与转归
JHEP Rep. 2024 Dec 20;7(4):101310. doi: 10.1016/j.jhepr.2024.101310. eCollection 2025 Apr.
5
High prevalence of short telomeres in idiopathic porto-sinusoidal vascular disorder.特发性门-体分流血管障碍患者端粒较短的高发率。
Hepatol Commun. 2024 Jul 22;8(8). doi: 10.1097/HC9.0000000000000500. eCollection 2024 Aug 1.
6
Co-expression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular disease.共表达基因网络分析揭示了门静脉窦状血管疾病中涉及的新调控途径。
J Hepatol. 2021 Oct;75(4):924-934. doi: 10.1016/j.jhep.2021.05.014. Epub 2021 May 28.
7
Genetic predisposition to porto-sinusoidal vascular disorder.肝内门-窦状隙血管疾病的遗传易感性。
Hepatology. 2024 Jun 20. doi: 10.1097/HEP.0000000000000973.
8
Making Sense of 'Porto-Sinusoidal Vascular Disorder': What Does It Mean for the Pathologist and the Patient?理解“门静脉窦状血管疾病”：它对病理学家和患者意味着什么？
Liver Int. 2025 Jan;45(1):e16196. doi: 10.1111/liv.16196.
9
The autoimmune landscape of Porto-sinusoidal vascular disorder: What the rheumatologist needs to know.Porto-窦周血管障碍的自身免疫景观：风湿病学家需要了解的内容。
Semin Arthritis Rheum. 2024 Aug;67:152467. doi: 10.1016/j.semarthrit.2024.152467. Epub 2024 May 20.
10
Link between persistent, unexplained gamma-glutamyltransferase elevation and porto-sinusoidal vascular disorder.持续性不明原因γ-谷氨酰转移酶升高与门-肝窦血管疾病之间的关联。
JHEP Rep. 2024 Jun 23;6(9):101150. doi: 10.1016/j.jhepr.2024.101150. eCollection 2024 Sep.
本文引用的文献
1
Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome.伴有门静脉高压的肝门-肝窦状隙血管疾病：自然病程与长期预后
J Hepatol. 2025 Jan;82(1):72-83. doi: 10.1016/j.jhep.2024.07.035. Epub 2024 Aug 22.
2
High prevalence of short telomeres in idiopathic porto-sinusoidal vascular disorder.特发性门-体分流血管障碍患者端粒较短的高发率。
Hepatol Commun. 2024 Jul 22;8(8). doi: 10.1097/HC9.0000000000000500. eCollection 2024 Aug 1.
3
Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population.端粒长度与美国人群肝病和死亡率的负相关关系。
Hepatol Commun. 2022 Feb;6(2):399-410. doi: 10.1002/hep4.1803. Epub 2021 Aug 28.
4
Hepatic manifestations of telomere biology disorders.端粒生物学紊乱的肝脏表现。
J Hepatol. 2018 Sep;69(3):736-743. doi: 10.1016/j.jhep.2018.05.006. Epub 2018 Jun 7.
5
The genetics and clinical manifestations of telomere biology disorders.端粒生物学障碍的遗传学和临床表现。
Genet Med. 2010 Dec;12(12):753-64. doi: 10.1097/GIM.0b013e3181f415b5.
Zotero 插件